ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,460Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 337

$676K Total Retail Price of All Prescriptions

Rank: 33 out of 337

256 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 256 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 256 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,808 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
LISINOPRIL 471 385 1 2
SIMVASTATIN 407 365 2 1
WARFARIN SODIUM 396 364 3 11
METOPROLOL TARTRATE 327 304 4 6
FUROSEMIDE 324 291 5 8
TRAZODONE HCL 297 218 6 16
METFORMIN HCL 263 216 7 12
OMEPRAZOLE 226 180 8 4
ATORVASTATIN CALCIUM 221 182 9 7
LANTUS 212 154 10 49
DONEPEZIL HCL 197 185 11 22
LEVOTHYROXINE SODIUM 170 166 12 5
RISPERIDONE 165 134 13 72
PANTOPRAZOLE SODIUM 163 144 14 36
AMLODIPINE BESYLATE 143 121 15 3
CITALOPRAM HBR 141 134 16 17
TAMSULOSIN HCL 134 114 17 25
MIRTAZAPINE 134 120 17 27
SYNTHROID 126 114 19 41
TRAMADOL HCL 125 109 20 32
SERTRALINE HCL 122 85 21 18
POLYETHYLENE GLYCOL 3350 118 113 22 47
QUETIAPINE FUMARATE 117 92 23 61
NAMENDA 101 101 24 35
BISOPROLOL FUMARATE 100 86 25 67
GABAPENTIN 98 70 26 20
HYDROCODONE-ACETAMINOPHEN 97 56 S3 27 13
KLOR-CON M20 94 91 28 65
BYSTOLIC 91 90 29 91
FINASTERIDE 88 83 30 83
NOVOLIN R 88 55 30 165
LOVASTATIN 87 72 32 24
CRESTOR 86 86 33 29
ATENOLOL 83 74 34 10
SPIRIVA 83 82 34 43
ALLOPURINOL 81 77 36 28
FENOFIBRATE 80 78 37 48
PRAVASTATIN SODIUM 79 79 38 14
DIGOXIN 76 76 39 58
EXELON 76 76 39 85
GENERLAC 71 54 41 164
ENALAPRIL MALEATE 71 69 41 37
DILTIAZEM 24HR ER 70 69 43 76
CLOPIDOGREL 70 70 43 42
BENZTROPINE MESYLATE 68 60 R 45 172
IPRATROPIUM-ALBUTEROL 62 62 46 96
PLAVIX 59 58 47 74
TRIAMCINOLONE ACETONIDE 59 31 47 181
OLANZAPINE 58 54 49 108
ALBUTEROL SULFATE 58 57 49 131
EVISTA 57 57 51 102
ESCITALOPRAM OXALATE 56 56 52 66
POTASSIUM CHLORIDE 56 56 52 62
NOVOLOG 54 33 54 106
DIOVAN HCT 53 53 55 88
LOSARTAN POTASSIUM 52 52 56 15
TRAVATAN Z 51 51 57 160
CLOZAPINE 51 51 57 94
ISOSORBIDE MONONITRATE ER 50 50 59 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 6, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.